Tag: Alternative Investments

GlaxoSmithKline defends itself against activist Elliott, recognizing need for ‘improved and sustained value’

GlaxoSmithKline GSK, +0.06% has issued a formal response to investor Elliott Management’s public letter this week calling for a shake-up of the pharmaceutical giant’s board of directors and executive team. GSK, one of the U.K.’s largest companies by market capitalization, backed its strategy and chief executive, Emma Walmsley, after the U.S. activist fund called on […]

Read More